Premium
Economic Aspects of Transesophageal Echocardiography and Atrial Fibrillation
Author(s) -
BECKER EDMUND R.,
CULLER STEVEN D.,
SHAW LESLEE J.,
WEINTRAUB WILLIAM S.
Publication year - 2000
Publication title -
echocardiography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 62
eISSN - 1540-8175
pISSN - 0742-2822
DOI - 10.1111/j.1540-8175.2000.tb01156.x
Subject(s) - medicine , atrial fibrillation , context (archaeology) , disease , cardiology , intensive care medicine , economic analysis , economics , paleontology , agricultural economics , biology
Cardiovascular disease is the leading cause of complications and death in the United States, affecting nearly 60 million Americans in 1998 and costing an estimated $274.2 billion. A major contributor to the costs of cardiovascular disease is atrial fibrillation (AF). AF is the most common sustained arrhythmia and affects > 2.2 million people and ˜ 5% of all persons over the age of 60. Transesophageal echocardiography (TEE) with short‐term anticoagulation has been proposed as a viable strategy to guide patients with AF. Here, we (1) review the current environmental context for a TEE‐guided approach, (2) summarize the existing literature on the economic aspects of TEE, and (3) outline an economic framework for an economic analysis of TEE investigation or any major clinical therapy. We conclude that more powerful analytical tools are evolving to analyze the important economic, clinical, and social aspects of a patient's medical encounter.